Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Clinical trial NCT07011589 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07011589
Sponsor: M. Peter Marinkovich
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa (EB)Epidermolysis Bullosa Acquisita Recessive Dystrophic Epidermolysis Bullosa Dystrophic Epidermolysis Bullosa

Start date: 2026-07-01
Primary completion: 2028-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.